AuroBlog - Aurous Healthcare Clinical Trials blog

DECEMBER 18, 2023

As antimicrobial resistance (AMR) poses a growing threat to global public health, challenging the effectiveness of antibiotics and other antimicrobial drugs, medical experts suggest whole genome sequencing as a viable option to identify and characterize the bacteria, viruses, fungi or parasites, along with their transmission pattern.

Bacteria 126

Bacteria Genome Genomics Drugs 126

Drug Discovery World

JUNE 29, 2023

This 24-page eBook sponsored by The Jackson Laboratory looks at the key use-cases for genomics and how it is improving drug discovery and development projects.

Genome 52

Genome Genomics Gene Editing Drugs 52

pharmaphorum

JANUARY 26, 2023

2022 was a banner year for genomics. In March, the collaborative T2T consortium published the first complete telomere-to-telomere sequence of the human genome, filling in the last 8% of the 3 billion base pairs that make up our DNA.

Genome 129

Genome Genomics Genome Project Genetics 129

Drug Discovery World

APRIL 16, 2024

The post rAAV Genome sequencing uncovers transgene integrity and packaging impurities appeared first on Drug Discovery World (DDW). A live Q&A session follows the webinar presentation.

Packaging 52

Packaging Packaging Genome Genomics 52

pharmaphorum

OCTOBER 12, 2022

David Del Bourgo (CEO and co-founder, Whitelab Genomics) has always been passionate about introducing disruptive, innovative technologies to markets. We founded Whitelab Genomics after realising the potential to use data, data science, and AI in a more systematic way to develop genomic therapies,” Del Bourgo says.

Genome 104

Genome Genomics Medicine Development 104

Pharmaceutical Technology

JULY 26, 2022

The last few months have marked the publication of research emerging from projects designed to collect and analyse genomic data on a wider scale than was previously thought possible. The post Magazine: Genomic projects exploit scale as clinical applications play catch-up appeared first on Pharmaceutical Technology.

Genome Project 130

Genome Project Genome Genomics Clinical Trials 130

Drug Discovery World

JANUARY 29, 2024

Leading experts in genomics, personalised medicine and drug discovery convened at the Precision Medicine Community Event in London to unveil the latest advancements shaping the future of healthcare. The post What are the key trends in genomics and precision medicine for 2024? appeared first on Drug Discovery World (DDW).

Genome 59

Genome Genomics Medicine Biobanking 59

Pharma Mirror

OCTOBER 4, 2021

Open source drug discovery was proposed in the past in connection with third-world diseases like tuberculosis and malaria, but it is in the context of first-world indications where it is needed most. In 2003 the Human Genome Project provided the first atlas. By Kambiz Shekdar, Ph.D.

Genome Project 299

Genome Project Drugs FDA Approval Genome 299

Drug Discovery World

DECEMBER 15, 2022

This is the latest episode of the free narrated DDW podcast , “Is genomic data the new frontier in drug discovery?” They are called “ Genomics boosts understanding of Covid-19 severity and susceptibility ” and “ Rare variant contribution to human disease ”. appeared first on Drug Discovery World (DDW).

Genome 52

Genome Genomics Biobanking Drugs 52

Pharmaceutical Technology

SEPTEMBER 11, 2023

Alexion has entered into a partnership with Verge Genomics to detect new drug targets for rare neurodegenerative and neuromuscular ailments.

Genome 147

Genome Genomics Drugs 147

Outsourcing Pharma

SEPTEMBER 12, 2023

The AstraZeneca-owned company Alexion has teamed up with Verge Genomics to deploy the U.S. startupâs drug discovery platform in the search for novel drug targets for rare neurodegenerative and neuromuscular diseases.

Genome 52

Genome Genomics Drugs Research 52

Bio Pharma Dive

SEPTEMBER 12, 2023

Johnson & Johnson and Bristol Myers Squibb have joined a group of new investors backing Rosana Kapeller’s startup, which launched in 2020 after incubating with GV.

Genome 171

Genome Genomics Drugs 171

Drug Discovery World

DECEMBER 15, 2022

This is the latest episode of the free narrated DDW podcast , “Is genomic data the new frontier in drug discovery?” They are called “ Genomics boosts understanding of Covid-19 severity and susceptibility ” and “ Rare variant contribution to human disease ”. appeared first on Drug Discovery World (DDW).

Genome 52

Genome Genomics Biobanking Drugs 52

pharmaphorum

JUNE 13, 2022

Canary Wharf’s bid to become a new hub for the life sciences sector in the UK has been given a boost following the decision by Genomics England to relocate to the development. Genomics England will move into space at the iconic One Canada Square skyscraper (pictured) that was the EMA’s home before the move to the Netherlands.

Genome 110

Genome Genomics Life Science Genome Project 110

Drug Discovery World

APRIL 10, 2023

Could India become an important centre of drug discovery innovation? Thanks to a new focus on R&D, increasing digitalisation and government investment, India is establishing itself as a significant player in drug discovery, and the Hyderabad life sciences hub has played a significant role in this.

Genome 52

Genome Genomics Drugs Life Science 52

Pharmaceutical Technology

SEPTEMBER 29, 2023

HitGen and the Structural Genomics Consortium entered a collaboration to discover drugs based on a DNA-encoded library (DEL).

DNA 130

DNA Genome Genomics Drugs 130

Pharmaceutical Technology

MAY 25, 2023

The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data to associate drug-related adverse events to their genetic makeup. The Yellow Card biobank will launch as a joint venture with the UK-government funded entity Genomics England on June 1.

Biobanking 130

Biobanking Genetics Genome Project Genome 130

Drug Discovery World

DECEMBER 29, 2023

Known as ‘CReATiNG’ (Cloning Reprogramming and Assembling Tiled Natural Genomic DNA), the method offers a simpler and more cost-effective approach to constructing synthetic chromosomes. The thing about most synthetic genomics research is that it involves building chromosomes or genomes from scratch using chemically synthesised DNA pieces.

Genome 52

Genome Genomics DNA Scientist 52

Drug Discovery World

JULY 19, 2023

UK-based precision medicine software provider Lifebit has agreed partnerships with two population genomic initiatives in Mexico and Brazil to help diversify genomic research and reduce health inequality in Latin America. The post Partners tackle global health challenges through genomics appeared first on Drug Discovery World (DDW).

Genome 52

Genome Genomics Genetics DNA 52

Drug Discovery World

NOVEMBER 7, 2022

Genomic healthcare data is critical to identify disease risk, ancestry, traits and response to medicines and aids in the development of new targeted therapies – precision medicines. In April 2003, after its launch in October 1990, the project was completed, generating the first sequence of the human genome. The origins .

Genome 98

Genome Genomics Development Genetics 98

Drug Discovery World

NOVEMBER 13, 2023

Genome sequencing has been used to study typhoid fever in a study in Zimbabwe and understand how the disease has evolved to be resistant to treatment. Working with local health authorities in Harare, they sequenced the genomes of 85 S. Typhoid fever claims over 135,000 lives annually. Typhi, known as 4.3.1.1. Since 2009, S.

Genome 52

Genome Genomics Scientist Vaccination 52

Drug Discovery World

SEPTEMBER 20, 2023

Eurofins Genomics has adopted Olink technology to advance proteomics research and accelerate its precision medicine programmes. Username or E-mail Password Remember Me Forgot Password The post Eurofins Genomics and Olink partner to advance proteomics research appeared first on Drug Discovery World (DDW). Not yet a DDW member?

Genome 59

Genome Genomics Research Clinical Trials 59

Outsourcing Pharma

JULY 20, 2023

The pharma giants AbbVie, Amgen, AstraZeneca, Bayer and Merck have been revealed as founding members of the Alliance for Genomic Discovery (AGD), a project aiming to accelerate drug development by collecting genomic data from underrepresented populations.

Genome 71

Genome Genomics Pharma Companies Development 71

BioSpace

OCTOBER 31, 2022

Verge Genomics dosed its first patient in a Phase I trial studying VRG50635, while Stealth Bio's SBT-272 was granted Orphan Drug designation by the FDA.

Genome 96

Genome Genomics Trials Drugs 96

Drug Discovery World

OCTOBER 25, 2023

bit.bio has launched the first offering from its new product range ioCRISPR-Ready Cells, which allow research and drug discovery scientists to knockout any gene of interest in glutamatergic neurons. With ioCRISPR-Ready Cells, we’re putting the future of genomics in the hands of every scientist.

Genome 52

Genome Genomics Gene Scientist 52

Drug Discovery World

AUGUST 3, 2023

This is the latest episode of the free DDW narrated podcast, “What lies in the future for genomics and big data?”, and “ Why a recent advancement is a giant leap for human genomics ”. Listen here: The post New podcast on the future for genomics and big data appeared first on Drug Discovery World (DDW).

Big Data 52

Big Data Genome Genomics Pharma Companies 52

BioPharma Reporter

OCTOBER 2, 2023

X-Chem, a company focused on drug discovery services, and the Structural Genomics Consortium (SGC), a public-private partnership accelerating drug discovery through open science, have partnered to create new chemical tools to study human proteins.

Genome 64

Genome Genomics Protein Drugs 64

Drug Discovery World

NOVEMBER 8, 2023

You will hear from Joseph R Peterson, PhD, CTO & Co-founder, SimBioSys, in his session on genomics and personalised medicine ‘Unlock novel cancer insights with multi-scale data integration’. Peterson will introduce PhenoScope, a data integration and visualisation platform that spans from genomes to tissues to organs to 3D digital twins.

Genome 52

Genome Genomics Research Medicine 52

Drug Discovery World

FEBRUARY 14, 2023

A collaboration between Automata and the Advanced Sequencing Facility (ASF) at The Francis Crick Institute hopes to unlock the power of integrated automation for genomics sample preparation. The post Automation for genomics could accelerate discovery appeared first on Drug Discovery World (DDW).

Genome 52

Genome Genomics Genetics Drugs 52

Drug Discovery World

AUGUST 3, 2023

This is the latest episode of the free DDW narrated podcast, “What lies in the future for genomics and big data?”, and “ Why a recent advancement is a giant leap for human genomics ”. Listen here: The post What lies in the future for genomics and big data? appeared first on Drug Discovery World (DDW).

Big Data 52

Big Data Genome Genomics Pharma Companies 52

Bio Pharma Dive

OCTOBER 25, 2022

“Every struggle that I've had has woven a sense of persistence into my DNA,” said Zhang, in a wide-ranging interview about leading a biotech startup as a young CEO.

Genome 265

Genome Genomics DNA Drugs 265

Drug Discovery World

MAY 24, 2023

You can also find The Drug Discovery World Podcast on Spotify , Google Play and Apple Podcasts. Listen here: The post New podcast on animal genomics, immunology and CGTs appeared first on Drug Discovery World (DDW).

Genome 52

Genome Genomics Gene Therapy Gene 52

BioSpace

AUGUST 30, 2020

When Bionano Genomics acquired Lineagen, Inc. in August, the genomic analysis company gained the final piece it needed to provide comprehensive structural variation detection for researchers and drug developers and a reimbursement pathway for clinicians who want to use its technology to replace c.

Genome 132

Genome Genomics Development Drugs 132

Drug Discovery World

AUGUST 16, 2023

Over the next two decades, it is quite possible that most new drugs approved could be based on some form of RNA, whether it be through its delivery or targeting the molecule itself. In actuality, the protein-coding portion of our genome is comparable in identity and number with the humble fruit fly or worm.

RNA 52

RNA Genome Genomics DNA 52

pharmaphorum

OCTOBER 19, 2022

million ($40 million) first-round financing that will be used to explore so-called ‘dark’ regions of the human genome. Nucleome’s platform adds 3D genomic information to a wealth of available genomic data, uncovering a new dimension of information that is disease as well as cell type-specific.

Genome 58

Genome Genomics Gene Gene Expression 58

Drug Discovery World

JUNE 21, 2023

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), Exact Sciences, Guardant Health, Illumina, MSD and Novartis have come together to launch the European Coalition for Access to Comprehensive Genomic Profiling (ECGP).

Genome 52

Genome Genomics Medicine Clinical Trials 52

BioSpace

DECEMBER 21, 2023

Eli Lilly has signed a multi-year contract with animal genomics biotech Fauna Bio to use its artificial intelligence platform to discover drug targets for obesity in a deal worth nearly half a billion dollars.

Genome 117

Genome Genomics Drugs 117